PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $242,000 | -44.7% | 193,650 | +4.6% | 0.00% | 0.0% |
| Q2 2022 | $438,000 | -28.9% | 185,114 | -6.9% | 0.00% | 0.0% |
| Q1 2022 | $616,000 | +273.3% | 198,891 | +666.6% | 0.00% | – |
| Q4 2021 | $165,000 | -76.6% | 25,944 | -63.4% | 0.00% | -100.0% |
| Q3 2021 | $705,000 | -72.4% | 70,923 | -63.2% | 0.00% | -75.0% |
| Q2 2021 | $2,555,000 | -53.7% | 192,911 | -38.9% | 0.01% | -52.0% |
| Q1 2021 | $5,521,000 | – | 315,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |